MIT and Harvard Develop Invisible, Off-the-Shelf Immune Cells to Revolutionize Cancer Treatment
MIT and Harvard researchers have developed a new engineered CAR-NK cell therapy that evades immune rejection, potentially enabling off-the-shelf cancer treatments with improved safety and effectiveness, demonstrated successfully in mouse models.